| 000 | 01543 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517215143.0 | ||
| 264 | 0 | _c20190508 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1465-542X | ||
| 024 | 7 |
_a10.1186/s13058-018-0968-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAllouchery, Violette | |
| 245 | 0 | 0 |
_aCirculating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. _h[electronic resource] |
| 260 |
_bBreast cancer research : BCR _c05 2018 |
||
| 300 |
_a40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xblood |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aEstrogen Receptor alpha _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aBeaussire, Ludivine | |
| 700 | 1 | _aPerdrix, Anne | |
| 700 | 1 | _aSefrioui, David | |
| 700 | 1 | _aAugusto, Laetitia | |
| 700 | 1 | _aGuillemet, Cécile | |
| 700 | 1 | _aSarafan-Vasseur, Nasrin | |
| 700 | 1 | _aDi Fiore, Frédéric | |
| 700 | 1 | _aClatot, Florian | |
| 773 | 0 |
_tBreast cancer research : BCR _gvol. 20 _gno. 1 _gp. 40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13058-018-0968-0 _zAvailable from publisher's website |
| 999 |
_c28398853 _d28398853 |
||